THE European Medicines Agency (EMA) has begun a process to review the safety of metamizol, a painkiller that is sold in Spain under the brand name Nolotil and has been blamed for dozens of expat deaths.
“EMA has started a review of medicines containing the painkiller metamizole following concerns that the measures in place to minimise the known risk of agranulocytosis may not be effective enough,” the agency said in a statement released on Friday.
Agranulocytosis is a known side effect of medicines that contain metamizol, and involves a sudden and sharp decrease in a type of white blood cell. The condition can lead to serious infections, which can be fatal.
The drug is known to have potentially deadly side effects for Northern Europeans.
The Olive Press is currently running a campaign…